The Centers for Disease Control and Prevention and the Food and Drug Administration are leaning toward resuming use of the Johnson & Johnson vaccine with a warning about blood clots, sources told CBS News. A decision is expected Friday, more than a week after the vaccine’s distribution was paused following reports of rare but dangerous blood clots in eight people under the age of 50.
“I think too many people may be scared off by taking the vaccine. They shouldn’t be, but perception is everything when it comes to vaccines,” said Dr. Peter Hotez, who works at the Texas Children’s Hospital Center for Vaccine Development.
